# PatientSafe Solutions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/patientsafe-solutions

- Industry: Healthcare IT
- Headquarters: San Diego, US
- Website: www.patientsafesolutions.com
- Total disclosed funding: $57M
- Latest round: Series C (Dec 18, 2013)
- Investors on record: 12

## About

PatientSafe Solutions, Inc. provides advanced clinical communication solutions aimed at enhancing healthcare workflows and improving patient care through innovative technology.Founded in 2002 and headquartered in San Diego, US, PatientSafe Solutions, Inc. specializes in clinical communication solutions. In April 2021, the company was acquired by Vocera Communications, Inc. for USD 36.00 mn, enabling further development of cloud-based communication support. The firm has completed a total of 10 deals since its inception.PatientSafe Solutions, Inc. specializes in clinical communication and workflow solutions, focusing on unifying healthcare teams and streamlining patient care processes. Their core offerings include advanced communication devices and software solutions, such as the Vocera Engage, Vocera Edge, and Vocera Smartbadge, which facilitate real-time voice communication and secure messaging. These products enhance connectivity among care teams, patients, and families, particularly in critical scenarios such as emergency care. Their solutions are tailored to the specific workflow needs of healthcare providers, integrating seamlessly with electronic health records to optimize operational efficiency.PatientSafe Solutions, Inc. generates revenue primarily through the sale of communication products and services, typically engaging in B2B transactions with healthcare organizations. They establish structured agreements, including subscription models for software and direct purchases of hardware devices. Their flagship products are crucial for enhancing clinical workflows, with pricing strategies aligned to the value of improved patient care and operational efficiency.Following its acquisition by Vocera Communications, Inc. in April 2021, PatientSafe Solutions, Inc. plans to accelerate its evolution to cloud-based solutions, enhancing communication and collaboration capabilities for frontline workers in healthcare. The company aims to expand its offerings to support a broader range of healthcare environments and is focused on utilizing recent funding to develop and launch new product lines that will improve patient care delivery. Through this strategic direction, PatientSafe Solutions, Inc. intends to strengthen its market presence in North America and explore opportunities in Europe and Asia by the end of 2023.

## Funding rounds

- Series C, Dec 18, 2013, $3M — TELUS Ventures
- Series C, Sep 24, 2013, $7M — SG Growth Capital
- Series C, Jan 7, 2013, $20M — Psilos Group, Camden Partners, TPG Biotech, Merck Global Health Innovation Fund
- Series B, Feb 8, 2010, $17M — American River Ventures, Menlo Ventures, Valhalla Partners, Psilos Group, Camden Partners, Integral Capital Partners, TPG Biotech, Shea Ventures
- Series D, Mar 6, 2007, $10M — American River Ventures, Menlo Ventures, Psilos Group, Integral Capital Partners, Shoreline Venture Management, Shea Ventures

## Investors

- American River Ventures (https://capitalatlas.ai/funds/american-river-ventures) — Series D, Series B
- Menlo Ventures (https://capitalatlas.ai/funds/menlo-ventures) — Series D, Series B
- Psilos Group (https://capitalatlas.ai/funds/psilos-group) — Series D, Series B, Series C
- Integral Capital Partners (https://capitalatlas.ai/funds/integral-capital-partners) — Series D, Series B
- Shoreline Venture Management (https://capitalatlas.ai/funds/shoreline-venture-management) — Series D
- Shea Ventures (https://capitalatlas.ai/funds/shea-ventures) — Series D, Series B
- Valhalla Partners (https://capitalatlas.ai/funds/valhalla-partners) — Series B
- Camden Partners (https://capitalatlas.ai/funds/camden-partners) — Series B, Series C
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series B, Series C
- Merck Global Health Innovation Fund (https://capitalatlas.ai/funds/merck-global-health-innovation-fund) — Series C
- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series C
- TELUS Ventures (https://capitalatlas.ai/funds/telus-ventures) — Series C